Turning Point Brands

Turning Point Brands aims to drive growth through modern oral nicotine products, expanded retail distribution and stronger brand awareness. The segment now accounts for 42% of revenue; net revenue rose from $325 million (2023) to $463 million (2025) and adjusted EBITDA reached $120 million. Management sees online sales as a proof of concept, plans substantial hiring for the field sales force and targets higher gross margins (up to ~70%) through U.S. production as well as a double-digit market share by 2030, but sees risks from costs, regulation and further investment needs. » More on de.investing.com

Crown Advisors sold 35,000 Turning Point Brands shares in Q1, an estimated $3.90 million trade that reduced the holding to 0.86% of the fund’s 13F assets. Turning Point reported Modern Oral net sales up 133% year‑over‑year to $52 million, total revenue up 16.8% to $124.3 million and raised full‑year Modern Oral guidance to as high as $225 million. However, net income fell 19%, Zig‑Zag segment sales dropped 22.4%, and higher marketing spend weighed on profits, making the fund’s trim appear a risk‑management move after recent gains rather than a loss of confidence. » More on finance.yahoo.com

The board of Turning Point Brands has declared a quarterly dividend of $0.08 per common share. It will be paid on July 10, 2026 to shareholders of record on June 19, 2026. The company is continuing its dividend growth trend; the dividend has been increased for nine consecutive years and most recently rose 14% year over year. Turning Point Brands produces and distributes branded consumer goods, including alternative smoking accessories, and reports a gross profit margin of 57%, while the stock is currently trading above its fair value. » More on de.investing.com